Black Diamond Therapeutics (BDTX)
US Market

Black Diamond Therapeutics (BDTX) Stock Price & Analysis


BDTX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.18 - $4.08
Previous Close$1.82
Average Volume (3M)151.42K
Market Cap
Enterprise Value-$28.27M
Total Cash (Recent Filing)$122.81M
Total Debt (Recent Filing)$28.14M
Price to Earnings (P/E)-0.7
May 16, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.51
Shares Outstanding36,481,146
10 Day Avg. Volume153,032
30 Day Avg. Volume151,424
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)0.57
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.31
Price Target Upside394.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Black Diamond Therapeutics’s price range in the past 12 months?
Black Diamond Therapeutics lowest stock price was $1.18 and its highest was $4.08 in the past 12 months.
    What is Black Diamond Therapeutics’s market cap?
    Currently, no data Available
    When is Black Diamond Therapeutics’s upcoming earnings report date?
    Black Diamond Therapeutics’s upcoming earnings report date is May 16, 2023 which is in 51 days.
      How were Black Diamond Therapeutics’s earnings last quarter?
      Black Diamond Therapeutics released its earnings results on Mar 09, 2023. The company reported -$0.59 earnings per share for the quarter, beating the consensus estimate of -$0.627 by $0.037.
        Is Black Diamond Therapeutics overvalued?
        According to Wall Street analysts Black Diamond Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Black Diamond Therapeutics pay dividends?
          Black Diamond Therapeutics does not currently pay dividends.
          What is Black Diamond Therapeutics’s EPS estimate?
          Black Diamond Therapeutics’s EPS estimate is -$0.61.
            How many shares outstanding does Black Diamond Therapeutics have?
            Black Diamond Therapeutics has 36,481,148 shares outstanding.
              What happened to Black Diamond Therapeutics’s price movement after its last earnings report?
              Black Diamond Therapeutics reported an EPS of -$0.59 in its last earnings report, beating expectations of -$0.627. Following the earnings report the stock price went down -13.69%.
                Which hedge fund is a major shareholder of Black Diamond Therapeutics?
                Among the largest hedge funds holding Black Diamond Therapeutics’s share is RA Capital Management. It holds Black Diamond Therapeutics’s shares valued at 5M.


                  Black Diamond Therapeutics Stock Smart Score

                  The Black Diamond Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Black Diamond Therapeutics

                  Black Diamond Therapeutics, Inc. engages in the biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms. The company was founded by Dr. David M. Epstein and Dr. Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.


                  Top 5 ETFs holding BDTX

                  Market Value
                  Smart Score
                  Fidelity Nasdaq Composite Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold BDTX. The ETFs are listed according to market value of BDTX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Syros Pharmaceuticals
                  HCW Biologics
                  Decibel Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis